Navigation Links
American College of Medical Genetics receives $13.5M NIH contract
Date:10/8/2008

The American College of Medical Genetics (ACMG), a national nonprofit medical and scientific professional association, announced that it has received a $13.5 million, 5-year contract from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) for the development of a National Newborn Screening Translational Research Network.

"This visionary contract will enable us to improve newborn screening, the care of patients identified in newborn screening, and our knowledge of the conditions that might be added to newborn screening," said Michael S. Watson, PhD, FACMG, executive director of the ACMG.

"At a time when newborn screening is expanding rapidly, this contract from the federal government provides the vehicle for research by the scientific community to study nationwide the most effective ways to introduce new screening tests. We can also assess how best to confirm diagnoses, initiate and follow existing and new treatments and improve their effectiveness, and educate parents and care providers about this growing realm of diagnosing and treating rare genetic disorders in children and giving them the chance to function normally," said Duane Alexander, M.D., Director, NICHD.

The NIH contract, the largest in ACMG history, will fund the establishment of the Newborn Screening Translational Research Network Coordinating Center (NBSTRNCC) whose activities will include, but are not limited to:

  1. Establish an organized network of state newborn screening programs and clinical centers.
  2. Develop, implement and refine a national research informatics system for investigators and policy makers that dovetails with established national clinical networks.
  3. Establish and administer an efficient, reliable repository of residual dried bloodspots that is either virtual or physical and comprised of those stored by state newborn screening programs and other res
    '/>"/>

Contact: Kathy Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1 2

Related biology news :

1. American Chemical Societys Weekly PressPac
2. Nanotech and synbio: Americans dont know whats coming
3. American Chemical Societys Weekly PressPac -- Sept. 24, 2008
4. News from the October 2008 Journal of the American Dietetic Association
5. American Physical Society announces Physics, a new, free, online publication
6. American Chemical Societys Weekly PressPac -- Sept. 10, 2008
7. New gene variant identified for nondiabetic end stage renal disease in African-Americans
8. Silent streams? Escalating endangerment for North American freshwater fish
9. American Chemical Societys Weekly PressPac -- Sept. 3, 2008
10. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
11. NYU, American Museum of Natural History receive $1.6 million NSF grant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...PRNewswire/ -- CBS Vision, the research division o...m Media Group company, today announced a new resea...ss to the CBS Television City research facility ho...he new venture, which marries the capabilities of ...es, will be called Communications Lab@OMD . ,,...
(Date:11/9/2009)...he hopeful news is that pediatric survival rates h...ewstreatments that enable survival often cause inf...e reached puberty currently have an opportunity to...r treatment, they may have their semen frozen and ...o not produce sperm, although their testicular tis...
(Date:11/9/2009)...ten is publishing a special issue "Beyond the Ori...rate Darwin,s On the Origin of Species which was p...tor and author of the lead article is Dr. Ulrich K...ionary biology at the University of Kassel in Germ...ble free of charge until 30 December 2009 on Sprin...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3Recovery Act funds expand studies of stem cell biology 10564 1Recovery Act funds expand studies of stem cell biology 10564 2Attention deficit hyperactivity problems associated with low folate levels in pregnant women 10559 1Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 1Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 2Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 3Beaumont U M Open Study of Drug for Advanced Breast Cancer 60244 4
...ing as more and younger people dye their hair, war...to dermatitis on the face and, in severe cases, fa... of hair dyes currently contain para-phenylenediam...h century, allergic reactions to PPD became such a... in Germany, France, and Sweden. , Current Euro...
...g have found an underlying molecular cause for one...ween deafness and the organization of liquid cryst...in the cochlea of the inner ear, sound waves cause... stimulate hair cells, which then trigger nerve im...archers have now learned that mutations in a prote...
...o treat a range of inflammatory conditions and can...he way aspirin works is not yet fully understood. ... of Biological Chemistry in April, Professor Bryan...ical Research, led a collaborative study that inve...ion of protein synthesis. , "Our research show...
Other Biology News:Scientists identify molecular cause for one form of deafness 2
(Date:11/6/2009)...rstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP"...ocherty, president and chief operating officer, wi...vestor Summit on November 10, 2009 at 4:00 PM at t...ill provide an overview of the Company,s leading p...terferon Alpha-2b. The slide show portion of the ...
(Date:11/6/2009)...FirstCall/ -- ,, 3Q09 Corporate Highlights: ...rketing Authorization to Astellas Pharma Europe Lt...ness activities Expanded management team to inclu...tor, Commercial Operations Appointed Bradford S. ...hairman , Upcoming 2009 Milestones: ,,...
(Date:11/6/2009)...- Intarcia Therapeutics, Inc. delivered two presen...ous delivery of exenatide) program for the treatme... Technology Meeting in San Francisco, CA: ,, (L.../SFTU126LOGO ) ,, Continuous Subcutaneous Del...ose, HbA1c and Reduces Weight in a 28-day Phase 1b...
(Date:11/5/2009)...FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today ...ter ended September 30, 2009. GenVec reported a ne...hree months ended September 30, 2009 compared to a... comparable quarter of 2008. For the nine months e....1 million ($0.15 per share), compared to a net lo...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...io is designed to work with many different audio d...Ariz. Watch out iPod and Sirius Radio ; here ...s DEMO conference , ,The company introduced a se...io and music files through cell phones in their ca... 700 technology industry insiders, media, and inve...
...gital optical modules, designed to sample high-ene...deployed in 70 deep holes in the Antarctic ice. Ph... Wis. Working under harsh Antarctic conditions, ... technicians has set in place the first critical e...th Pole. , ,The successful deployment - in a 1.5 m...
...Wis. The Wisconsin Alumni Research Foundation ,... of Wisconsin-Madison, will be among the recipient...rch 15 at a White House ceremony. The annual award...standing contributions to the Nations economic, e...velopment and commercialization of technology prod...
Other Biology Technology:Motorola debuts iRadio for anywhere, anytime music 2First pieces of Antarctic deep-space particle detector are in place 2First pieces of Antarctic deep-space particle detector are in place 3First pieces of Antarctic deep-space particle detector are in place 4First pieces of Antarctic deep-space particle detector are in place 5
Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam
PI/RNase Staining Buffer Solution from BD Biosciences Pharmingen
Goat Anti-HSPC150 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human Macrophage-stimulating protein receptor Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Biology Products: